Background Treatment for chronic hepatitis C (CH‐C) is rapidly changing and moving away
from an interferon and ribavirin‐based therapy to interferon‐free ribavirin‐free all oral …

Despite the availability of highly effective therapy for hepatitis C virus (HCV) infection, few
patients receive treatment. Barriers arising at multiple levels, from diagnosis to specialist …

Abstract In summer 2015, a Saudi 1000-bed tertiary care hospital experienced a serious
outbreak among patients of Middle Eastern Respiratory Syndrome (MERS); during which …

Aims The aim was to examine whether a type 2 diabetes mellitus (T2DM) diagnosis
increases the odds of psychological distress, a worsening in overall quality of life, and a …

Huge Gap Between Clinical Efficacy and Community Effectivene... : Medicine Huge Gap
Between Clinical Efficacy and Community Effectiveness in the Treatment of Chronic Hepatitis C …

Chronic infection with the hepatitis C virus (HCV) is a leading cause of global morbidity and
mortality. Although recent advances in antiviral therapy have led to significant improvements …

Chronic infection with the hepatitis C virus (HCV) has a profound effect on health‐related
quality of life (HRQoL)–with fatigue, depression and neurocognitive deficits among the most …

Title. Stigma in the context of hepatitis C: concept analysis. Aim. This paper is a report of a
concept analysis of stigma in the context of hepatitis C. Background. Stigma is a complex …

In the past decade, there has been an increasing emphasis by researchers regarding the
stigmatization of people who are hepatitis C positive as they seek health care. Because the …

Patients with chronic hepatitis C virus (HCV) infection experience a range of symptoms
including depression, fatigue and neurocognitive deficits, impairing quality of life …